Dosage and administration
Two sprays twice daily. Hold in mouth for 30 seconds.
Two sprays twice daily. Hold in mouth for 30 seconds.
(in each spray): 6.66% of Agnus Castus 12X, Avena Sativa 6X, Damiana 12X, Epimedium Grandiflorum 30C, Ginkgo Biloba 12X, Hepar Suis 6X, Human Growth Hormone 26X, Hypothalamus (Suis) 12X, Lycopodium Clabatum 12X, Orchitinum (Suis) 6X, Serotonin (Hydrochloride) 30C, Spermidine 12X, 30X, Spermine 12X, 30X; 0.10% of Testosterone 6X.
For temporary relief of sexual debility from nervous prostration, for enhancing sexual function, nervous exhaustion causing lack of sexual desire.**
**Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.
If pregnant or breast-feeding, ask a health professional before use.
Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.
Do not use if tamper evident seal is broken or missing.
Store in a cool, dry place.
Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.
Two sprays twice daily. Hold in mouth for 30 seconds.
For temporary relief of sexual debility from nervous prostration, for enhancing sexual function, nervous exhaustion causing lack of sexual desire.**
**Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.
Citric Acid, Demineralized Water, Glycerin, Sodium Benzoate.
Dist. by Energique, Inc.
201 Apple Blvd
Woodbine, IA 51579 800-869-8078
ENERGIQUE
SINCE 1987
HOMEOPATHIC REMEDY
MALE BALANCE
1 fl. oz. (30 ml)
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 44911-0126-1 | 2021-12-22 | C162847 | 48780-1 | ba0f9c33-15e7-a910-e053-dadaa90a0b85 | DRUG FACTS |
| 44911-0126-1 | 2021-01-29 | C162847 | 48780-1 | ba0f9c33-15e7-a910-e053-dadaa90a0b85 | DRUG FACTS |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| AVENA SATIVA FLOWERING TOP | ACTIVE INGREDIENT | MA9CQJ3F7F | 1 | |
| CHASTE TREE | ACTIVE INGREDIENT | 433OSF3U8A | 1 | |
| EPIMEDIUM GRANDIFLORUM TOP | ACTIVE INGREDIENT | 137PC46F89 | 1 | |
| GINKGO | ACTIVE INGREDIENT | 19FUJ2C58T | 1 | |
| LYCOPODIUM CLAVATUM SPORE | ACTIVE INGREDIENT | C88X29Y479 | 1 | |
| PORK LIVER | ACTIVE INGREDIENT | 6EC706HI7F | 1 | |
| SEROTONIN HYDROCHLORIDE | ACTIVE INGREDIENT | GKN429M9VS | 1 | |
| SOMATROPIN | ACTIVE INGREDIENT | NQX9KB6PCL | 1 | |
| SPERMIDINE | ACTIVE INGREDIENT | U87FK77H25 | 1 | |
| SPERMINE | ACTIVE INGREDIENT | 2FZ7Y3VOQX | 1 | |
| SUS SCROFA HYPOTHALAMUS | ACTIVE INGREDIENT | N6R0856Z79 | 1 | |
| SUS SCROFA TESTICLE | ACTIVE INGREDIENT | KM02613O28 | 1 | |
| TESTOSTERONE | ACTIVE INGREDIENT | 3XMK78S47O | 1 | |
| TURNERA DIFFUSA LEAFY TWIG | ACTIVE INGREDIENT | RQ2CFA7WWJ | 1 | |
| AVENA SATIVA FLOWERING TOP | ACTIVE MOIETY | MA9CQJ3F7F | 1 | |
| CHASTE TREE | ACTIVE MOIETY | 433OSF3U8A | 1 | |
| EPIMEDIUM GRANDIFLORUM TOP | ACTIVE MOIETY | 137PC46F89 | 1 | |
| GINKGO | ACTIVE MOIETY | 19FUJ2C58T | 1 | |
| LYCOPODIUM CLAVATUM SPORE | ACTIVE MOIETY | C88X29Y479 | 1 | |
| PORK LIVER | ACTIVE MOIETY | 6EC706HI7F | 1 | |
| SEROTONIN | ACTIVE MOIETY | 333DO1RDJY | 1 | |
| SOMATROPIN | ACTIVE MOIETY | NQX9KB6PCL | 1 | |
| SPERMIDINE | ACTIVE MOIETY | U87FK77H25 | 1 | |
| SPERMINE | ACTIVE MOIETY | 2FZ7Y3VOQX | 1 | |
| SUS SCROFA HYPOTHALAMUS | ACTIVE MOIETY | N6R0856Z79 | 1 | |
| SUS SCROFA TESTICLE | ACTIVE MOIETY | KM02613O28 | 1 | |
| TESTOSTERONE | ACTIVE MOIETY | 3XMK78S47O | 1 | |
| TURNERA DIFFUSA LEAFY TWIG | ACTIVE MOIETY | RQ2CFA7WWJ | 1 | |
| ANHYDROUS CITRIC ACID | INACTIVE INGREDIENT | XF417D3PSL | 1 | |
| GLYCERIN | INACTIVE INGREDIENT | PDC6A3C0OX | 1 | |
| SODIUM BENZOATE | INACTIVE INGREDIENT | OJ245FE5EU | 1 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | 1 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 44911-0126 | 44911-0126-1 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| AVENA SATIVA FLOWERING TOP | MA9CQJ3F7F | ACTIB |
| PORK LIVER | 6EC706HI7F | ACTIB |
| SUS SCROFA TESTICLE | KM02613O28 | ACTIB |
| TESTOSTERONE | 3XMK78S47O | ACTIB |
| CHASTE TREE | 433OSF3U8A | ACTIB |
| TURNERA DIFFUSA LEAFY TWIG | RQ2CFA7WWJ | ACTIB |
| GINKGO | 19FUJ2C58T | ACTIB |
| SUS SCROFA HYPOTHALAMUS | N6R0856Z79 | ACTIB |
| LYCOPODIUM CLAVATUM SPORE | C88X29Y479 | ACTIB |
| SPERMIDINE | U87FK77H25 | ACTIB |
| SPERMINE | 2FZ7Y3VOQX | ACTIB |
| SOMATROPIN | NQX9KB6PCL | ACTIB |
| EPIMEDIUM GRANDIFLORUM TOP | 137PC46F89 | ACTIB |
| SEROTONIN HYDROCHLORIDE | GKN429M9VS | ACTIB |
| ANHYDROUS CITRIC ACID | XF417D3PSL | IACT |
| GLYCERIN | PDC6A3C0OX | IACT |
| SODIUM BENZOATE | OJ245FE5EU | IACT |
| WATER | 059QF0KO0R | IACT |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | CONCENTRATE / ORAL | 20 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION / INTRAMUSCULAR | 450 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION, EMULSION / INTRAVENOUS | 24100 mg | ||
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | PASTE / ORAL | 28 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SPRAY, METERED / NASAL | 13 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | CAPSULE, COATED / ORAL | 14.21 mg | ||
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | GEL / TOPICAL | 5 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SYSTEM / IONTOPHORESIS | 168.1 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | TABLET / ORAL | 42 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION, SOLUTION / INTRAMUSCULAR | 15 %w/v | ||
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | INJECTION / INTRAMUSCULAR | 864 mg | ||
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | FILM, SOLUBLE / BUCCAL | 2 mg | ||
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | ELIXIR / ORAL | 5.02 mg/5ml | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | AEROSOL, FOAM / TOPICAL | 21 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION / SUBCUTANEOUS | 450 mg | ||
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | INJECTION, EMULSION / INTRAVENOUS | 0.1 %w/v | ||
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | SYRUP / ORAL | 80 mg | ||
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | INJECTION, SOLUTION / SUBCUTANEOUS | 25 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION / ORAL | 32400 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | CLOTH / TOPICAL | 0.05 mg/mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SUSPENSION / OPHTHALMIC | 58 mg | ||
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | AEROSOL / TOPICAL | 0.08 %w/w | ||
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | FILM / BUCCAL | 9 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SPRAY / NASAL | 22.3 mg/1ml | ||
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | SUSPENSION, EXTENDED RELEASE / ORAL | 24 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | GEL / TOPICAL | 500 mg | ||
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | SOLUTION / TOPICAL | 0.1 %w/v | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | LIQUID / ORAL | 2400 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | CONCENTRATE / ORAL | 1800 mg | ||
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | TABLET, CHEWABLE, EXTENDED RELEASE / ORAL | 12 mg | ||
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | CAPSULE, LIQUID FILLED / ORAL | 360 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION/ DROPS / OPHTHALMIC | 12 mg | ||
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | SUSPENSION / ORAL | 320 mg | ||
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | SOLUTION / ORAL | 3900 mg | ||
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | INJECTION / INTRAMUSCULAR | 101 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SUSPENSION/ DROPS / OPHTHALMIC | 2.5 %w/v | ||
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | CREAM / TOPICAL | 1 mg | ||
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | TABLET, EXTENDED RELEASE / ORAL | 312 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | OINTMENT / TOPICAL | NA | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION / NASAL | 25 mg/1ml | ||
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | SUSPENSION/ DROPS / ORAL | 23 mg | ||
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | SOLUTION/ DROPS / AURICULAR (OTIC) | 1 mg | ||
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | TABLET, EFFERVESCENT / ORAL | 840 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION, SUSPENSION / SUBCUTANEOUS | 1.6 %w/v | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | CAPSULE / ORAL | 3487 mg | ||
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | TABLET / ORAL | 197 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION / AURICULAR (OTIC) | 63.64 %w/v | ||
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | TABLET, DELAYED RELEASE / ORAL | 0.34 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SUSPENSION, EXTENDED RELEASE / ORAL | 2000 mg | ||
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | GRANULE, EFFERVESCENT / ORAL | 60 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | DROPS / NASAL | 10 mg/1ml | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | CREAM / VAGINAL | 60 mg | ||
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | SOLUTION / ORAL | 660 mg | ||
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | PASTE, DENTIFRICE / DENTAL | 0.5 %w/w | ||
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | LIQUID / INTRAVENOUS | 18 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | TABLET, COATED / ORAL | 1 mg | ||
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | SUSPENSION/ DROPS / OPHTHALMIC | 0.05 %w/v | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | PASTE / ORAL | 3822 mg | ||
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | FILM / SUBLINGUAL | 11 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | AEROSOL / TOPICAL | 3 %w/w |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 229ebf1a-109b-475c-b57f-ff006bed28dd | 7c4841eb-688c-4479-9681-cf4c3ca34463 | 2021-12-22 | Warnings | 229ebf1a-109b-475c-b57f-ff006bed28dd 7c4841eb-688c-4479-9681-cf4c3ca34463 |
Adverse event summaries are temporarily unavailable. Other product information remains available.